Smart and injectable hydrogels for cancer treatment and other biomedical applications.
1/5 보강
The tumor microenvironment (TME) has specific features distinct from normal tissues, making these stimuli suitable for responsive and localized therapy.
APA
Cheah KE, Yeoh PSQ, et al. (2026). Smart and injectable hydrogels for cancer treatment and other biomedical applications.. Biomaterials advances, 180, 214624. https://doi.org/10.1016/j.bioadv.2025.214624
MLA
Cheah KE, et al.. "Smart and injectable hydrogels for cancer treatment and other biomedical applications.." Biomaterials advances, vol. 180, 2026, pp. 214624.
PMID
41308530 ↗
Abstract 한글 요약
The tumor microenvironment (TME) has specific features distinct from normal tissues, making these stimuli suitable for responsive and localized therapy. Injectable hydrogels have been identified as promising site-specific drug delivery carriers due to their ability to conform to irregular anatomical spaces and form in situ depots. Smart hydrogels, in particular, are engineered to respond to TME-relevant stimuli to facilitate controlled and sustained release of therapeutic agents locally within the tumor environment. This review provides an overview of injectable smart hydrogels based on cross-linking methods and how they influence injectability, self-healing, and responsiveness. It also discusses new designs of dual- and multi-responsive hydrogels that can respond to the multifactorial nature of the TME. Incorporating nanomaterials into hydrogel matrices is also covered, offering enhanced functionality for various biomedical applications. While the primary interest is cancer therapy, the design principles and methodologies introduced here are equally relevant to other biomedical applications such as wound healing, regenerative medicine, and inflammation-targeted therapy.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.